Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piramal Critical Care markets a broad portfolio of commercialized hospital generic drugs globally. Its core strengths lie in inhaled anesthetics like sevoflurane, desflurane, and isoflurane; intrathecal baclofen therapy; opioid analgesics; anti-infectives such as linezolid injection; rare disease oral therapies like miglustat. The company has expanded its product range through strategic acquisitions from companies including Janssen Pharmaceutica NV and Mallinckrodt LLC. All major products are approved and marketed internationally across more than one hundred countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Piramal Critical Care.